Peer Review History
| Original SubmissionNovember 13, 2020 |
|---|
|
PONE-D-20-35741 A concerted probiotic activity to inhibit periodontitis-associated bacteria PLOS ONE Dear Dr. Georg Conrads, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 4, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Abdelwahab Omri, Pharm B, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting paper that addresses an important topic, the inhibition of periodontal pathogens by commensals and probiotics. While the methodology is fairly straightforward, the novelty of work lies in the testing of combinations of organisms and examining the impact of the pathogenic organisms on the commensals. The dependence of L. reuteri on glycerol for an antagonistic effect is also an important advance. Specific comments 1. Discussion of non-statistically significant results should be limited and more cautious. For example, its not clear that the inhibitory potential of K12 was diluted by M18 (line 262), when none of the conditions were statistically significant. 2. There is no need to repeat numbers in the text which are presented in the figures and table. 3. Line 112-113. The authors should state a biological hypothesis rather than a statistical one. 4. Introduction. the meaning of 'a common abbreviation used' is unclear. Reviewer #2: Overview: The manuscript “A concerted probiotic activity to inhibit periodontitis-associated bacteria” describes a straightforward approach to characterize effects of several probiotic bacteria on periodontal pathogenic bacteria in vitro. The authors performed co-cultures of strains, with single and double strains of probiotics cultured with each pathogen, then analyzed growth of each strain after 48 h by measuring abundance of genomic DNA via qRT-PCR. In general, this was an interesting study that certainly has some applications in dental hygiene. I have a few minor comments and one major comment about the manuscript and research. Minor comments: 1. The manuscript is well written, and English is very good. However, a careful review by a native English speaker would help to polish the language. 2. Lines 112-113: “Our null hypothesis was that there is no significant difference of pure culture versus co-culture.” For clarity, what difference are you referring to? It would also be nice if you could come back to this hypothesis at the end of the paper and state whether or not it was confirmed. 3. Lines 248-249: “without glycerol supplementation the pathogen cell number increased more than 5-fold…” Why would this happen? Can you provide some more details as to why the pathogens would grow higher in the PTA – glycerol condition than on their own? 4. Table 2: The order of the Lr PTA w/o gly and Lr PTA with gly is swapped from Fig. 1. That was a bit confusing to me for a second. I recommend swapping the two columns to be consistent with the order in Fig. 1. 5. Figure 2- I’m not sure if this is necessary. It may be better placed in the Supplementary Info, as it is mostly a repeat of the data in Table 2. 6. Lines 320-321: “Thus, perfect for the application as a probiotic…” This sentence is rather confusing and could benefit from being re-worded to improve clarity. Major issues: 1. Lines 117-119. The authors isolated three different strains of bacteria from commercially available lozenges. However, there is no description of how or whether the isolates were characterized and confirmed. Were the isolates verified to be the strains they report? If so, please explain how the validation performed. If not, the strains should be verified. Reviewer #3: This study assessed the probiotic effects of S. salivarius strains M18 and K12, S. oralis subsp. dentisani 7746, or L. reuteri ATCC PTA 5289 (or a combination thereof) on periodontal pathogens, P. gingivalis ATCC33277, F. nucleatum ATCC 25586, P. intermedia ATCC 25611 and A. actinomycetemcomitans ATCC 33384. L. reuteri glycerol-dependent antagonistic properties (production of reuterin) was also examined. The study also investigated the impact of the periopathogens on the growth of the probiotic strains. All analysis was done via qRT-PCR. Overall, the paper is straight forward and presents relatively new information. Experiments performed also appear sound and appropriately controlled. There are several aspects of the paper that could be improved though. The resolution of the figures should be improved; they appear to be of poor quality. Figure 2 does not present any new data so should be omitted. The discussion section also lacks some important and relevant information. While it states that L. reuteri had the “best anti-pathogen effect” and discusses in detail what aspects could be improved as a probiotic therapy, it is also worth mentioning that Lactobacilli can be acidogenic and aciduric in certain conditions and are often found to be associated with caries. And while it can be effective in clearing periodontal bacteria in vitro, the impact it can have to the overall oral ecology is important to note. Additionally, the discussion section specifically could be improved if several grammar issues can be corrected with further proofreading/editing (some examples are listed below). 1. Line 139 and throughout the paper: growth inhibition was assessed quantifying bacterial genomes via qPCR. Hence, phrases like“comparing cell numbers” or referring to the detected bacterial genome as cell numbers is inaccurate (since CFUs weren’t done to actually count cell numbers). 2. Line 140: were biofilms grown under anaerobic conditions? If so, please specify here. It is mentioned in the discussion section/line 433 but not specified here. 3. Line 141: The growth condition authors used/BHI both and autoclaved human saliva. Please include a reference or explain why this condition was selected. 4. Line 154: Collection of biofilms. The author states cells were simply “harvested by transferring culture from wells”. Was any scraping of the biofilm with subsequent sonication step involved? 5. It could help readers follow the results better if figures in Figure 1 are labeled A-D, and referenced in text/results section 6. Line 259: Authors state P. intermedia inhibition is enhanced via a synergistic effect of K12+7746, compared to single species. Is there a significant decrease of P.intermedius genome in K12+7746 vs. K12 or 7746 only? 7. Line 259 and on: Instead of organizing the results section this way, it would help if all the findings of each graph within Figure 1 is written together (instead of splitting single probiotic species impact on specific periodontal bacteria and then going back later to stating the results on mixed-species impact on that periodontal bacteria) 8. Figure 2 presents nothing new. Table 2 is fine the way it is but Figure 2 does not really add to the manuscript. Figure 2 should be removed. 9. Line 321: “producer-activation” ? Are authors referring more detection of genome as “activation”? Sentence should be rewritten. Referring it to as “persistence” of that probiotic strain seems more accurate. 10. Line 344-345: Please add “respectively” after the numbers in the parentheses 11. Line 345: “However” should be changed to “Although” or “While” and omit “but” 12. Figure 4: Title of figure should be F. nucleatum, as the format in Figure 1, since the bacterial genome reported are of F. nucleatum when grown with two different strains of L. reuteri. 13. Line 358: remove “Anyway” and also throughout the manuscript 14. Line 375: please change “gain more attention” to “are gaining more attention” 15. Line 391: Omit however 16. Line 411-413: Just simply state it as a possible explanation (take out “an explanation for this,…cannot be given”). 17. Line 435: Should be “the activity is not reduced much by autoclaving” 18. Line 435-436: Change to “..was not determined in our experiment and we did not test whether addition of B12 would have further..” 19. Line 445: “Learning from biotechnology”…? As reported in the literature…? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A concerted probiotic activity to inhibit periodontitis-associated bacteria PONE-D-20-35741R1 Dear Dr. Georg Conrads, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abdelwahab Omri, Pharm B, Ph.D Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-20-35741R1 A concerted probiotic activity to inhibit periodontitis-associated bacteria Dear Dr. Conrads: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abdelwahab Omri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .